igf 1 and ghk cu The GH/IGF-1 axis in obesity: pathophysiology therapeutic considerations Proposed signaling pathways for IGF-I
Description
It's a nickname, not a brand
As can be seen in the literature on the peptide BPC 157, most, if not all, studies are limited to small animal models (i.e., rats and mice), and the routes of administration are also limited to a small number, making it impossible to determine the overall efficacy of the drug
The copper component is critical
Therapeutically administered AMPs represent a new direction in non-antibiotic periodontal management working with the body's own defenses rather than against the microbiome broadly
